COPD (Chronic Obstructive Pulmonary Disease) — NZ Condition Guide | KiwiMeds

What is COPD?

Chronic Obstructive Pulmonary Disease (COPD) is a long-term lung condition that makes it hard to breathe, caused by damage to the airways and lung tissue. It is an umbrella term covering chronic bronchitis (inflammation and narrowing of the airways with excess mucus) and emphysema (damage to the air sacs in the lungs). COPD is a leading cause of death and disability in New Zealand, particularly affecting older adults who have smoked.

Symptoms

COPD symptoms develop slowly and include a persistent cough (often with mucus), shortness of breath — especially during activity, wheezing, chest tightness, and frequent respiratory infections. Symptoms may be mild at first and people often dismiss them as “smoker’s cough.” By the time many people are diagnosed, significant lung damage has already occurred. COPD cannot be reversed, but progression can be slowed with treatment.

Causes and Risk Factors

Smoking is the cause of about 90% of COPD cases — both current and ex-smokers are at risk. Long-term exposure to occupational dust, chemicals, and fumes also causes COPD. A rare genetic condition called alpha-1 antitrypsin deficiency can cause COPD in non-smokers. In NZ, Māori and Pacific peoples have higher rates of COPD, partly reflecting higher rates of smoking.

Diagnosis

COPD is diagnosed with spirometry — a breathing test that measures how much air you can blow out and how fast. A diagnosis of COPD is confirmed when spirometry shows airflow obstruction that does not fully reverse with a bronchodilator. Your GP may also arrange a chest X-ray or CT scan. Many people with COPD are undiagnosed — if you are a current or ex-smoker with any breathing symptoms, ask your GP about a spirometry test.

Treatment in New Zealand

The most important step in COPD treatment is quitting smoking — this is the only intervention proven to slow the progression of lung damage. Pharmac funds a range of COPD medications including short-acting bronchodilators (salbutamol, ipratropium), long-acting bronchodilators (tiotropium/Spiriva, salmeterol), combination inhalers, and inhaled corticosteroids. Pulmonary rehabilitation (a supervised exercise and education programme) is highly effective and available through most DHBs/Te Whatu Ora. For end-stage COPD, oxygen therapy may be needed.

NZ-Specific Information

Smoking cessation support is free in New Zealand through Quitline (0800 778 778) and most GP practices. Pharmac funds nicotine replacement therapy and varenicline (Champix) for eligible patients. The Asthma + Respiratory Foundation NZ supports people with COPD. Pulmonary rehabilitation referrals are available through your GP or respiratory specialist.

Frequently Asked Questions

Can COPD be cured? No, but quitting smoking and using medications correctly can significantly slow its progression and improve quality of life. Is it safe to exercise with COPD? Yes — pulmonary rehabilitation includes supervised exercise and is one of the most effective COPD treatments. Will I need oxygen? Only in advanced COPD where blood oxygen levels are low. Most people with COPD never need home oxygen.

Supplements That May Support Management

⚠️ Important: The supplements listed below have varying levels of clinical evidence. They are not a substitute for prescribed medications and should only be considered as adjunctive support under the guidance of a qualified healthcare professional. Always inform your GP or pharmacist before commencing any supplement, as interactions with prescribed medicines are possible.

• Vitamin D — Vitamin D deficiency is highly prevalent in people with COPD and is independently associated with reduced lung function, increased exacerbation frequency, and impaired respiratory muscle function. Supplementation in deficient individuals has demonstrated reductions in exacerbation frequency.
• N-Acetylcysteine (NAC) — NAC is a mucolytic and antioxidant that replenishes glutathione levels. High-dose NAC (600 mg twice daily) has demonstrated modest reductions in COPD exacerbation rates in some trials, with its role as a mucolytic agent also supporting airway clearance.
• Omega-3 Fatty Acids — Anti-inflammatory omega-3 supplementation may help attenuate chronic airway inflammation in COPD. Emerging evidence supports a modest benefit in reducing systemic inflammation markers and improving exercise tolerance.
• Magnesium — Magnesium supports bronchial smooth muscle relaxation and may improve respiratory muscle function. Deficiency is common in COPD, particularly in those on diuretics.
• Vitamin C and E (antioxidants) — Oxidative stress is a central mechanism in COPD pathophysiology. Antioxidant vitamins may provide modest supportive benefit, particularly vitamin C as part of a diet rich in fresh fruits and vegetables.

Relevant Vaccinations

Individuals living with COPD (chronic obstructive pulmonary disease) may benefit from the following vaccinations. Please discuss your vaccination status with your GP or practice nurse, as eligibility and funding through the New Zealand National Immunisation Schedule may apply.

• Influenza (annual) — Influenza is a leading cause of acute COPD exacerbations and hospitalisation. Annual influenza vaccination is among the most effective interventions for reducing COPD exacerbation frequency and is funded in NZ.
• Pneumococcal (PCV20 or PPSV23) — COPD significantly increases susceptibility to pneumococcal pneumonia. Both PCV20 and PPSV23 are recommended and funded for people with COPD in New Zealand.
• COVID-19 — COPD is one of the highest-risk conditions for severe COVID-19 respiratory outcomes. Maintaining up-to-date COVID-19 vaccination is strongly recommended.
• Pertussis (booster) — Whooping cough can cause severe exacerbations in people with COPD. A pertussis booster is recommended if not received within the past 10 years.

Dietary Guidance

Evidence-based dietary modifications play a meaningful role in the management of COPD (chronic obstructive pulmonary disease). The following foods are generally recommended as part of a balanced, condition-appropriate diet. A referral to a registered dietitian may be beneficial for personalised nutritional planning.

• High-protein foods (lean meat, fish, eggs, legumes) — Malnutrition and loss of respiratory muscle mass (sarcopenia) are common in advanced COPD. Adequate protein intake (1.2–1.5 g/kg/day) is essential to maintain respiratory muscle function and exercise capacity.
• Antioxidant-rich fruits and vegetables — A diet rich in antioxidants (vitamin C, vitamin E, carotenoids) is associated with better lung function preservation in COPD. Aim for ≥5 servings of varied colourful produce per day.
• Oily fish — Omega-3 fatty acids from oily fish reduce systemic inflammation, which is elevated in COPD and contributes to both lung function decline and cardiovascular comorbidity.
• Small, frequent meals — People with COPD often experience early satiety due to hyperinflation compressing the stomach. Eating smaller, more frequent, energy-dense meals reduces the metabolic work of breathing and supports nutritional adequacy.
• Limit simple sugars and carbonated drinks — High carbohydrate intake increases carbon dioxide production (respiratory quotient), which may worsen breathlessness in those with limited ventilatory reserve. Complex carbohydrates are preferred.

Related Conditions & Medications

Related medications: Salbutamol, Tiotropium (Spiriva). Related conditions: Asthma.